Ponatinib and Blinatumomab for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Subgroup Analysis from a Phase II Study

Autor: Short, Nicholas, Kantarjian, Hagop, Jain, Nitin, Huang, Xuelin *, Montalban-Bravo, Guillermo, Kadia, Tapan M., Daver, Naval, Chien, Kelly S., Alvarado, Yesid, Garcia-Manero, Guillermo, Issa, Ghayas C., Macaron, Walid *, Haddad, Fadi *, Kwari, Monica, Delumpa, Ricardo *, Mayor, Ejiroghene *, Deen, Wuliamatu *, Thankachan, Jennifer *, Loiselle, Christopher *, Rivera, Juan *, Milton, Anna *, Waller, Lourdes *, Banks, Glenda *, Garris, Rebecca *, Konopleva, Marina, Ravandi, Farhad, Jabbour, Elias
Zdroj: In Blood 15 November 2022 140 Supplement 1:513-515
Databáze: ScienceDirect